Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

157.95
Delayed Data
As of Apr 20
 -0.77 / -0.49%
Today’s Change
128.58
Today|||52-Week Range
163.75
+17.30%
Year-to-Date

Today’s Trading

Previous close158.72
Today’s open158.87
Day’s range156.69 - 159.01
Volume259,664
Average volume (3 months)438,016
Market cap$9.1B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+17.52%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+8.79%
P/E ratio19.8
Price/Sales5.10
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.29+1.34%
ALKSAlkermes Plc-0.13-0.28%
SGENSeattle Genetics Inc+0.11+0.22%
TSROTESARO Inc-0.63-1.21%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)$2.83
Annual revenue (last year)$1.6B
Annual profit (last year)$487.8M
Net profit margin30.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
President &
Chief Operating Officer
Daniel N. Swisher
Corporate headquarters
Dublin, Dublin

Forecasts